Abbott | ABT - 負債





負債 変化する 日付
Abbott USD 13.86B 919M 2025-12
Agilent USD 3.35B 0 2025-12
AtriCure USD 73.38M 3.35M 2025-12
Baxter International USD 9.78B 68M 2025-12
Becton, Dickinson and Co. USD 19.54B 358M 2025-12
Bio-Rad Laboratories USD 1.39B 9.2M 2025-12
Boston Scientific USD 11.44B 610M 2025-12
Cooper Companies USD 2.5B 5.6M 2025-12
Danaher USD 18.48B 66M 2026-03
Dexcom USD 1.24B 900K 2026-03
Edwards Lifesciences USD 600M 105.4M 2026-03
Globus Medical USD 118.66M 687K 2025-12
Insulet USD 949.2M 65.6M 2025-12
Integra LifeSciences USD 2.04B 6.27M 2026-03
Intuitive Surgical USD 0 0 2025-03
J&J USD 47.93B 2.14B 2025-12
Masimo USD 485.9M 100.3M 2026-03
Medtronic USD 28.07B 1.03B 2025-12
Merit Medical Systems USD 821.57M 420K 2025-12
Pfizer USD 63.73B 231M 2026-03
Smith & Nephew USD 3.32B 334M 2024-12
Solventum Corp USD 7.91B 97M 2025-03
Stryker USD 14.22B 635M 2026-03
Tandem Diabetes Care USD 444.48M 4.81M 2025-12
Teleflex USD 2.73B 43.5M 2025-12
Terumo JPY 159.87B 14.97B 2025-09
Thermo Fisher Scientific USD 39.39B 3.7B 2025-12
Zimmer Biomet Holdings USD 7.47B 48.1M 2026-03